BEIJING, June 25, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it attended the 8th Biennial Chinese Sleep Research Society ("CSRS") Conference and 20th Anniversary Celebration of CSRS, held in Beijing, from June 13-15, 2014, to showcase its Morpheus OX System and work station.
Ms. Reyna Dong, Marketing Director of Dehaier's Sleep Respiratory Products Division stated, "The CSRS conference is one of the industry's most authoritative and highest level academic conferences. Nationally-and internationally-renowned scholars and experts in the sleep industry attended the conference. The CSRS conference gave us opportunities to showcase our products and solutions for some of the luminaries in our industry. We are encouraged by the positive feedback and great interest from scholars and experts in our state-of-the-art Morpheus OX System. We will use the attention from our presentation at the conference as a springboard for marketing our new products in China."
About the Chinese Sleep Research Society Biennial Conference
The Biennial Chinese Sleep Research Society Conference is the industry's most comprehensive educational and networking event for industry veterans to discuss sleep respiratory diseases. The 20th Anniversary Celebration invited world famous experts to discuss developments in diagnosis and treatment of respiratory diseases, and present academic and industry research.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and ten software copyrights. More information may be found at http://www.dehaier.com.cn
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Dehaier Medical Systems Limited +86 10-5166-0080 Surie Liu Janice Wang